Skip to main navigation Skip to search Skip to main content

BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

  • S. J. Dawson
  • , N. Makretsov
  • , F. M. Blows
  • , K. E. Driver
  • , E. Provenzano
  • , J. Le Quesne
  • , L. Baglietto
  • , G. Severi
  • , G. G. Giles
  • , C. A. McLean
  • , G. Callagy
  • , A. R. Green
  • , I. Ellis
  • , K. Gelmon
  • , G. Turashvili
  • , S. Leung
  • , S. Aparicio
  • , D. Huntsman
  • , C. Caldas*
  • , P. Pharoah
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

272 Scopus citations

Fingerprint

Dive into the research topics of 'BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry